Chronic pelvic pain (HTB) remains a relevant multidisciplinary problem. Its symptoms are the result of interaction between psychological factors and dysfunction immune, neurological endocrine systems. HTB is serious problem for women. Approximately 14% women experienced at least once in their lives. grueling related to significant costs incidence, its etiology multifactorial, which often compli...

Chronic Pelvic pain is a major cause of morbidity in reproductive years of women. This study was conducted to evaluate the laparoscopic findings in women with chronic pelvic pain, correlating its accuracy with clinical pelvic examination and managing treatable lesions at the same sitting. This was a prospective observational study conducted at Mahatma Gandhi University of Medical Sciences and T...

OBJECTIVE The etiology of chronic pelvic pain is disputed and multifactorial. We studied the effect of Mensendieck somatocognitive therapy aimed at reducing physical pain by changing posture, movement and respiration patterns combined with standard gynecological treatment. STUDY DESIGN Women with chronic pelvic pain unexplained by pelvic pathology were randomized into 2 groups: (1) standard g...

The various investigative procedures used in clinical, laboratory, and imaging evaluations for the patient presenting with chronic pelvic pain are discussed and categorized as mandatory, recommended, or optional procedures. These categories primarily serve to rule out underlying pathology because there is no diagnostic test for chronic prostatitis/chronic pelvic pain syndrome (CPPS). Mandatory ...

Pelvic inflammatory disease or pelvic inflammatory disorder (PID) is an infection of the upper part of the female reproductive system namely the uterus, fallopian tubes, or the ovaries. Around 2% of women are affected. The main complication is the formation of a pyosalpinx (abscess) and ectopic pregnancy is 6 times more likely after a pelvic infection. Often there may be no symptoms. Signs and ...

INTRODUCTION Chronic pelvic pain (CPP) affects >1 million UK women. Annual healthcare costs are estimated at >£150 million. Proven interventions for CPP are limited, and treatment is often unsatisfactory. Gabapentin is increasingly prescribed due to reports of effectiveness in other chronic pain conditions, but there are insufficient data supporting value in CPP specifically. The mechanism by w...